Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroblastoma 8Prostatic Neoplasms 3Precancerous Conditions 3Glioma 3Astrocytoma 3Adenomatous Polyposis Coli 3Skin Neoplasms 2Sarcoma, Ewing 2Osteosarcoma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Basal Cell 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rhabdoid Tumor 1Osteosarcoma Recurrent 1Oligodendroglioma 1Non-melanoma Skin Cancer 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, Follicular 1Lung Neoplasms 1Keratosis, Actinic 1Gastritis, Atrophic 1Esophageal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Colonoscopy 13Polyethylene Glycols 3Surgical Instruments 2Endoscopic Mucosal Resection 2sodium phosphate 1prucalopride 1picosulfate sodium 1peppermint oil 1maltodextrin 1Sulindac 1Simethicone 1Ringer's Lactate 1Reference Standards 1Proflavine 1Optical Imaging 1Occult Blood 1Narrow Band Imaging 1MoviPrep 1Menthol 1Mass Screening 1Iohexol 1Hydroxyethyl Starch Derivatives 1Folic Acid 1Eflornithine 1Diatrizoate Meglumine 1Diagnosis, Computer-Assisted 1Defecation 1Colonography, Computed Tomographic 1Citric Acid 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Colonic Polyps × Eflornithine × Clear all
NCT01245816 2015-04-24

A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)

Cancer Prevention Pharmaceuticals, Inc.

Phase 3 Withdrawn
Gastrointestinal

Colonic Polyps, Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡